LAG3 and breast carcinoma: In estrogen receptor-negative breast cancers LAG-3+ iTILs demonstrated higher expression and were correlated with negative prognostic factors: young age, large tumor size, high proliferation, HER2E and basal-like breast cancer subtypes [103].